1. Home
  2. ONMD vs ELOX Comparison

ONMD vs ELOX Comparison

Compare ONMD & ELOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneMedNet Corp

ONMD

OneMedNet Corp

HOLD

Current Price

$0.70

Market Cap

42.1M

Sector

N/A

ML Signal

HOLD

Logo Eloxx Pharmaceuticals Inc. Common Stock

ELOX

Eloxx Pharmaceuticals Inc. Common Stock

N/A

Current Price

$17.45

Market Cap

60.3M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ONMD
ELOX
Founded
2006
N/A
Country
United States
United States
Employees
N/A
7
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
42.1M
60.3M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
ONMD
ELOX
Price
$0.70
$17.45
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
165.4K
33.9K
Earning Date
05-13-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
83.33
41.67
EPS
N/A
N/A
Revenue
$1,359,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
111.35
N/A
52 Week Low
$0.49
$10.00
52 Week High
$4.22
$23.40

Technical Indicators

Market Signals
Indicator
ONMD
ELOX
Relative Strength Index (RSI) 53.00 56.03
Support Level $0.58 $16.50
Resistance Level $0.70 $19.66
Average True Range (ATR) 0.04 2.10
MACD 0.00 0.13
Stochastic Oscillator 57.87 83.10

Price Performance

Historical Comparison
ONMD
ELOX

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.

About ELOX Eloxx Pharmaceuticals Inc. Common Stock

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.

Share on Social Networks: